Inhibiting GRB2 using a liposome-incorporated oligonucleotide to suppress GRB2 protein expression (L-GRB2) inhibits proliferation of BCR-ABL-positive leukemia cells both in vitro and in vivo20. Here, ABL1 is linked to leukemia.